Sign In
Buy BDX
$170.12
-0.0900 (-0.0529%)
At Close: Aug 04, 2026
BD (BDX) Inks Buyout Deal to Expand Smart Connected Care Suite
01:21pm, Wednesday, 05'th Jun 2024
BD's (BDX) latest agreement is likely to unlock new future value-creation opportunities and expand its portfolio of smart connected care solutions.
NEW YORK, NY / ACCESSWIRE / June 4, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Becton, Dickinson and Company (NYSE: BDX
Becton Dickinson Buys Critical Care Unit From Edwards Lifesciences for $4.2B
04:45pm, Monday, 03'rd Jun 2024
Shares of Becton Dickinson (BDX) advanced close to 3% Monday as the maker of syringes and other medical devices announced it was buying the Critical Care product unit of Edwards Lifesciences (EW) for
Three Reasons to Retain BD (BDX) Stock in Your Portfolio Now
01:01pm, Monday, 03'rd Jun 2024
BD's (BDX) robust product portfolio raises optimism about the stock.
Becton Dickinson to Acquire Edwards Lifesciences' Unit for $4.2 Billion in Cash
08:25am, Monday, 03'rd Jun 2024
The buyer intends to fund deal with a combination of $1 billion in cash and $3.2 billion of new debt in a transaction that is one of its largest of many.
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln
07:43am, Monday, 03'rd Jun 2024
Edwards Lifesciences on Monday said it has agreed to sell its Critical Care products unit to Becton Dickinson in an all-cash transaction valued at $4.2 billion.
Edwards Lifesciences to sell its critical care product group for $4.2 billion to Becton Dickinson
06:40am, Monday, 03'rd Jun 2024
Shares of Edwards Lifesciences Corp. EW, -1.14% rallied 3% in premarket trading Monday, after the company announced an agreement to sell its critical care product group to Becton Dickinson & Co. BDX,
Edwards Lifesciences to Sell Critical Care to BD
06:30am, Monday, 03'rd Jun 2024
IRVINE, CA--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced it has entered into a definitive agreement to sell its Critical Care product group to BD (Becton, Dickinson and Company) (N
Combination unlocks new future value-creation opportunities and is expected to be immediately accretive to BD revenue growth, adjusted gross margin, adjusted operating margin and adjusted EPS Expands
Becton, Dickinson And Polaris: The Market Is Dead Wrong About These Dividend Aristocrat Bargains
07:00am, Saturday, 01'st Jun 2024
Value investing may be out of favor due to the success of tech darlings like Nvidia and Amazon. However, value investing can still be done safely and responsibly, and generate exceptional returns, inc
NEW YORK, NY / ACCESSWIRE / May 30, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Becton, Dickinson and Company (NYSE:BDX)
My Best Dividend Aristocrats For June 2024
11:37pm, Tuesday, 28'th May 2024
The ProShares S&P 500 Dividend Aristocrats ETF hits its first speed bump in April, dropping by 4.69%. Some of this loss has been recovered in May. I present 3 strategies that can theoretically beat th
Panagora Asset Management Inc. Sells 276 Shares of Becton, Dickinson and Company (NYSE:BDX)
08:26am, Monday, 20'th May 2024
Panagora Asset Management Inc. trimmed its position in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) by 2.2% during the 4th quarter, according to the company in its most recen
BD's (BDX) FDA-Approved Test to Offer Wider Testing Access
01:31pm, Friday, 17'th May 2024
BD's (BDX) receipt of the FDA's clearance for the use of self-collected vaginal specimens for HPV testing is likely to improve screening access to a wider female population.
NEW YORK, NY / ACCESSWIRE / May 16, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Becton, Dickinson and Company (NYSE:BDX)
